CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	59.05B -24.3%
Revenue (ttm)	4.35B +111.2%
Net Income	1.02B
EPS	0.73
Shares Out	1.39B
PE Ratio	58.15
Forward PE	39.80
Dividend	0.02 (0.04%)
Ex-Dividend Date	May 29, 2025

Volume	8,312,833
Open	42.18
Previous Close	42.40
Day's Range	42.01 - 43.35
52-Week Range	22.50 - 55.38
Beta	-0.01
Analysts	Strong Buy
Price Target	59.47 (+37.25%)
Earnings Date	Aug 18, 2026

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,369
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Analyst Summary

According to 3 analysts, the average rating for 300765 stock is "Strong Buy." The 12-month stock price target is ¥59.47, which is an increase of 37.25% from the latest price.

Price Target

¥59.47

(37.25% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 14, 2026

Data Sources Report a data error